Discovery of a shared therapeutic target in granulomatosis with polyangiitis and gastric tumor microenvironment
- PMID: 37394889
- DOI: 10.1111/1756-185X.14672
Discovery of a shared therapeutic target in granulomatosis with polyangiitis and gastric tumor microenvironment
Comment on
-
Meta-analysis confirmed genetic susceptibility conferred by multiple risk variants from CTLA4 and SERPINA1 in granulomatosis with polyangiitis.Int J Rheum Dis. 2022 Jul;25(7):811-819. doi: 10.1111/1756-185X.14354. Epub 2022 Jun 3. Int J Rheum Dis. 2022. PMID: 35656856
References
REFERENCES
-
- Banerjee P, Kumar U, Khetarpal P, Senapati S. Meta-analysis confirmed genetic susceptibility conferred by multiple risk variants from CTLA4 and SERPINA1 in granulomatosis with polyangiitis. Int J Rheum Dis. 2022;25(7):811-819.
-
- Jiang L, Hu LG. Serpin peptidase inhibitor clade a member 1-overexpression in gastric cancer promotes tumor progression in vitro and is associated with poor prognosis. Oncol Lett. 2020;20(6):278.
-
- Louthrenoo W, Kasitanon N, Wongthanee A, Kuwata S, Takeuchi F. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Int J Rheum Dis. 2021;24(11):1378-1385.
-
- Zengin Acemoglu SS, Turk I, Ozsoy S, Koker MY, Sat B. Adult case of chronic granulomatous disease mimicking granulomatosis with polyangiitis. Int J Rheum Dis. 2022;0000:0000. doi:10.1111/1756-185X.14507
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical